Abstract

Machine learning techniques combined with wearable electronics can deliver accurate short-term blood glucose level prediction models. These models can learn personalized glucose–insulin dynamics based on the sensor data collected by monitoring several aspects of the physiological condition and daily activity of an individual. Until now, the prevalent approach for developing data-driven prediction models was to collect as much data as possible to help physicians and patients optimally adjust therapy. The objective of this work was to investigate the minimum data variety, volume, and velocity required to create accurate person-centric short-term prediction models. We developed a series of these models using different machine learning time series forecasting techniques suitable for execution within a wearable processor. We conducted an extensive passive patient monitoring study in real-world conditions to build an appropriate data set. The study involved a subset of type 1 diabetic subjects wearing a flash glucose monitoring system. We comparatively and quantitatively evaluated the performance of the developed data-driven prediction models and the corresponding machine learning techniques. Our results indicate that very accurate short-term prediction can be achieved by only monitoring interstitial glucose data over a very short time period and using a low sampling frequency. The models developed can predict glucose levels within a 15-min horizon with an average error as low as 15.43 mg/dL using only 24 historic values collected within a period of sex hours, and by increasing the sampling frequency to include 72 values, the average error is reduced to 10.15 mg/dL. Our prediction models are suitable for execution within a wearable device, requiring the minimum hardware requirements while at simultaneously achieving very high prediction accuracy.

Highlights

  • Type 1 diabetes mellitus (DM1) is a disease characterized by high blood sugar levels that result from the body’s inability to produce insulin

  • For the three different methods used to develop the patient models, acceptable predictions were achieved for prediction horizon (PH) of 15 and 30 min, with average root mean square error (RMSE) lower than 20 mg/dL for autoregressive integrated moving average (ARIMA) (Figure 2a) and random forest (RF) (Figure 2b), and lower than

  • As with the previous experiment, we again observed that the patient models developed using the RF method achieve a better performance for each different sample frequency (SF) considered

Read more

Summary

Introduction

Type 1 diabetes mellitus (DM1) is a disease characterized by high blood sugar levels that result from the body’s inability to produce insulin. Glucose homeostasis is a closed-loop system that is able to regulate blood glucose levels [1]. The pancreas houses the β cells, which are sensitive to high glucose levels and produce insulin, a strong hormone able to reduce hyperglycemia. This regulation is not possible in DM1. This is an autoimmune disease in which the body destroys the insulin-producing cells in the pancreas, and is the more aggressive form of the disease.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call